Key facts
- Rob Medical’s last known valuation is $22.5M (Sep 2017).
- It has raised $143.7M; the latest was Later Stage VC in Jul 2025.
- Notable investors include Tailong VC, Hangzhou Capital, Taikun Fund, MGI Tech.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Rob Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Rob Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Rob Medical
Developer of medical robot-based technology designed to solve the insufficient high-quality medical resources. The company focuses on medical robots, including surgical robots, rehabilitation robots, assistant robots, and service robots, and uses these technologies in clinical fields of natural orifice surgery and ultrasonic diagnosis, enabling patients to enjoy high-quality medical care.
- Sector
- Information Technology
- HQ
- Shenzhen, China
- Founded
- 2015
- Employees
- 10
- Website
- docrobo.com/
- Ownership
- Privately Held (backing)
Rob Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rob Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rob Medical in its N-PORT filings yet. We sweep new filings monthly.